|
Cell Implants Improve Motor Control in Parkinson's Patients
Are you searching for some inside or more defined advice on parkinsons disease article ? Here's an up-to-date report from parkinsons disease article experts who ought to be able to give you a clearer understanding.
Human retina cell implants improved motor symptoms in a group of Parkinson's disease (PD) patients who participated in a recent study, and they appeared to be safe and well tolerated, according to a report published in the Archives of Neurology.
Parkinson's disease is a neurodegenerative disorder characterized by tremor, rigidity, postural instability and slowed ability to start and continue movements. Most patients with PD require therapy with the medication levodopa to control symptoms three to five years after a diagnosis of PD.
Motor Fluctuations
However, disease progression and long-term oral treatment with levodopa may lead to the development of motor fluctuations and difficulty in performing voluntary movements (dyskinesias).
Human retinal pigment epithelial (RPE) cells produce levodopa and can be isolated from post-mortem human eye tissue, grown in culture, and implanted into the brain attached to microcarriers. (The retinal pigment epithelium is the pigment cell layer found in the inner layer of the retina of the eye.)
MobilityThere has been much advancement in the field of wheelchairs, specifically mobility wheelchairs. But now there is something even more versatile, ..... Sometimes the most important aspects of a subject are not immediately obvious. Keep reading to get the complete picture. These remaining paragraphs might leave you with a whole new way of thinking when in consideration of parkinsons disease article.
If you are somewhat uncertain by what you've read to this point, don't despair. Everything ought to be crystal clear by the time you finish.
These implants have been shown to ease motor problems in animal models of Parkinson's disease in earlier research, according to the article.
48 Percent Improvement
Natividad P. Stover, MD, of the University of Alabama at Birmingham and colleagues conducted an open-label pilot study to evaluate the effect of unilateral implantation of human RPE cells attached to gelatin microcarriers.
Six patients with advanced Parkinson's disease received cell implants, which were inserted into the brain tissue. The researchers performed efficacy evaluations at one and three months after surgery, and then at six, nine, 12, 15, 18 and 24 months. Yearly follow-up visits are ongoing and will continue.
"The implants were well tolerated," the authors report. "We observed an average improvement of 48 percent at 12 months after implantation in the Unified Parkinson's Disease Rating Scale motor subscore with the patient in the off state, which was sustained through 24 months."
Quality of Life
"Improvement was also observed in activities of daily living, quality of life and motor fluctuations. No off-state dyskinesias were observed," they add.
"On the basis of the motor improvement and tolerability observed in this open-label study, a randomized, double-blind, placebo-controlled study has been initiated to more objectively test efficacy and continue to assess safety," the authors conclude.
Nicole Weaver is a health journalist for
Daily News Central, an online publication that delivers breaking news and reliable health information to consumers, healthcare providers, and industry professionals.
Article Source: http://EzineArticles.com/?expert=Nicole_Weaver
Mobility AIDSPeople who have a limited amount of strength in their arms and upper body usually purchase a power wheel chair. For this reason, .....
Now is a good time to note down any issues of interest covered above. The act of jotting it down on paper will help you further bear in mind the importance regarding parkinsons disease article.
|
